◆英語タイトル:Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C0587
◆発行会社(調査会社):
GlobalData
◆発行日:2018年7月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Editas Medicine Inc (EDIT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Editas Medicine Inc (Editas Medicine) formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its in-licensed clustered regularly interspaced short palindromic repeats (CRISPR) technology. The company’s pre-clinical pipeline spans investigational candidates for the treatment of genetic and infectious diseases of eye, hematologic diseases, cancer, and diseases of muscle, lung and liver. The company works in collaboration with various biotechnology and pharmaceutical companies and research institutions. Editas Medicine is headquartered in Cambridge, Massachusetts, the US.
Editas Medicine Inc Key Recent Developments
May 03,2018: Editas Medicine Announces First Quarter 2018 Results and Update
Apr 30,2018: Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the American Society of Gene & Cell Therapy Annual Meeting
Mar 28,2018: Editas Medicine Appoints James C. Mullen As Board Chairman
Mar 06,2018: Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
Feb 16,2018: Editas Medicine Appoints Jessica Hopfield, Ph.D., As Board Director
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Editas Medicine Inc – Key Facts 6
Editas Medicine Inc – Key Employees 7
Editas Medicine Inc – Key Employee Biographies 8
Editas Medicine Inc – Major Products and Services 9
Editas Medicine Inc – History 10
Editas Medicine Inc – Company Statement 11
Editas Medicine Inc – Locations And Subsidiaries 12
Head Office 12
Section 2 – Company Analysis 13
Company Overview 13
Editas Medicine Inc – Business Description 14
Editas Medicine Inc – Corporate Strategy 15
Editas Medicine Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Editas Medicine Inc – Strengths 16
Editas Medicine Inc – Weaknesses 17
Editas Medicine Inc – Opportunities 18
Editas Medicine Inc – Threats 19
Editas Medicine Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Editas Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Editas Medicine Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Editas Medicine Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
May 03, 2018: Editas Medicine Announces First Quarter 2018 Results and Update 30
Apr 30, 2018: Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the American Society of Gene & Cell Therapy Annual Meeting 32
Mar 06, 2018: Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update 35
Jan 08, 2018: Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference 37
Nov 07, 2017: Editas Medicine Announces Third Quarter 2017 Results and Update 38
Aug 09, 2017: Editas Medicine Announces Second Quarter 2017 Results and Update 40
Aug 09, 2017: Editas Medicine Achieves Milestone Under Juno Therapeutics Collaboration for Technical Progress Towards Overcoming the Tumor Microenvironment 42
May 31, 2017: Editas Medicine Names Andrew Hirsch to Board of Directors 43
May 15, 2017: Editas Medicine Announces First Quarter 2017 Results and Update 44
May 13, 2017: Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas 46
Section 6 – Appendix 47
Methodology 47
Ratio Definitions 47
About GlobalData 51
Contact Us 51
Disclaimer 51
List of Tables
Editas Medicine Inc, Key Facts 6
Editas Medicine Inc, Key Employees 7
Editas Medicine Inc, Key Employee Biographies 8
Editas Medicine Inc, Major Products and Services 9
Editas Medicine Inc, History 10
Editas Medicine Inc, Key Competitors 20
Editas Medicine Inc, Ratios based on current share price 21
Editas Medicine Inc, Annual Ratios 22
Editas Medicine Inc, Annual Ratios (Cont...1) 23
Editas Medicine Inc, Interim Ratios 25
Editas Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Editas Medicine Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Editas Medicine Inc, Recent Deals Summary 29
Currency Codes 47
Capital Market Ratios 47
Equity Ratios 48
Profitability Ratios 48
Cost Ratios 49
Liquidity Ratios 49
Leverage Ratios 50
Efficiency Ratios 50
List of Figures
Editas Medicine Inc, Performance Chart (2013 - 2017) 24
Editas Medicine Inc, Ratio Charts 26
Editas Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Editas Medicine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28